Stachyra T, Péchereau MC, Bruneau JM et al. Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-b-lactam b-lactamase inhibitor. Antimicrob Agents Chemother 2010; 54:5132-8.
Ehmann DE, Jahić H, Ross PL et al. Avibactam is a covalent, reversible, non-b-lactam b-lactamase inhibitor. Proc Natl Acad Sci USA 2012; 109:11663-8.
Ehmann DE, Jahic H, Ross PL et al. Kinetics of avibactam inhibition against class A, C, and D b-lactamases. J Biol Chem 2013; 288:27960-71.
Lahiri SD, Giacobbe RA, Johnstone MR et al. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C b-lactamase enzyme. J Antimicrob Chemother 2014; 69:2942-6.
Barnaud G, Labia R, Raskine L et al. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett 2001; 195:185-90.
De Meester F, Joris B, Reckinger G et al. Automated analysis of enzyme inactivation phenomena. Application to b-lactamases and DD-peptidases. Biochem Pharmacol 1987; 36:2393-403.
Porres-Osante N, Dupont H, Torres C et al. Avibactam activity against extended-spectrum AmpC b-lactamases. J Antimicrob Chemother 2014; 69:1715-6.
